{"nct_id":"NCT02603393","title":"Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD","status":"COMPLETED","status_verified_date":"2019-01","start_date":"2015-11-20","start_date_type":"ACTUAL","primary_completion_date":"2017-07-18","primary_completion_date_type":"ACTUAL","completion_date":"2017-07-18","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}